2017

1. A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN)

   Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 28, Núm. 7, pp. 1517-1522

2. The role of mTOR inhibition as second-line therapy in metastatic renal carcinoma: clinical evidence and current challenges

   Expert Review of Anticancer Therapy, Vol. 17, Núm. 3, pp. 217-226